Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

28.37
+1.284.72%
Post-market: 28.800.4300+1.52%19:59 EDT
Volume:293.51K
Turnover:8.27M
Market Cap:55.88M
PE:- -
High:28.80
Open:27.06
Low:26.85
Close:27.09
52wk High:391.58
52wk Low:12.38
Shares:1.97M
Float Shares:1.97M
Volume Ratio:0.85
T/O Rate:14.90%
Dividend:1.98
Dividend Rate:6.98%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

FTC Suing Hims & Hers Health for Allegedly Sending User Info to Meta and Snap, Reuters Reports

MT Newswires Live
·
Jul 30

Hims & Hers Shares Down 12.2%; Reuters Reports US FTC Sues Co for Sending User Health Info to Meta, Snap

THOMSON REUTERS
·
Jul 30

US FTC Suing Hims & Hers for Sending User Health Info to Meta, Snap

Reuters
·
Jul 30

Exclusive - U.S. Federal Trade Commission is Suing Hims & Hers over Billing, Cancellation and Privacy Practices, FTC Spokesperson Says

THOMSON REUTERS
·
Jul 30

Hims & Hers Health (HIMS) Receives a Hold from Truist Financial

TIPRANKS
·
Jul 29

Is Today’s Dip a Buying Opportunity for Hims & Hers Health (HIMS) Stock?

TIPRANKS
·
Jul 25

Hims & Hers falls -10.3%

TIPRANKS
·
Jul 25

Truist Raises Price Target on Hims & Hers Health to $27 From $23, Keeps Hold Rating

MT Newswires Live
·
Jul 24

Hims & Hers Health Inc : Truist Securities Raises Target Price to $27 from $23

THOMSON REUTERS
·
Jul 24

Moderately bullish activity in Hims and Hers Health with shares up 3.39%

TIPRANKS
·
Jul 24

Hims & Hers Health is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 24

FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules

Reuters
·
Jul 24

Why Is Hims & Hers Health Stock Surging on Thursday?

Benzinga
·
Jul 24

Hims Gains After FDA Panel Votes to Place Popularly Used Peptide Bpc-157 on Compounding List

Reuters
·
Jul 24

Hims & Hers Health Shares up 10% After FDA Advisory Panel Votes to Place Bpc-157 Peptide on Allowed Pharmacy Compounding List

THOMSON REUTERS
·
Jul 24

Hims & Hers Shares up 2% After Telehealth Firm Urged FDA to Broaden Access to Some Peptides in Panel Meeting

THOMSON REUTERS
·
Jul 23

Peptides Could Soon Become Widely Available in the U.S. Here's What Happens Next.

Dow Jones
·
Jul 23

Hims & Hers Health Inc : Citigroup Raises Target Price to $35 from $28

THOMSON REUTERS
·
Jul 23

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares Valued at $229,075.99

Reuters
·
Jul 21

Trump's FDA May Soon Back Peptides. Should You Buy In?

Dow Jones
·
Jul 18